Browse by category

PlacidWay, a global medical tourism platform, has released industry research examining how the rapid adoption of non-surgical medications is influencing international healthcare travel patterns, including changing demand for bariatric surgery and increased interest in post-bariatric aesthetic care. The analysis identifies a shift in the traditional medical tourism pathway, particularly in medical tourism for bariatric surgery, as some patients who previously considered travel

Results from Syntis Bio’s 28-day multiple ascending dose (MAD) portion of its Phase 1/1b SYNTIETY-1 clinical trial, evaluating SYNT-101 as a potential treatment of obesity, revealed that SYNT-101 was well tolerated at all dose levels in the MAD cohorts (n=23), with no discontinuations and no dose reductions in any of the cohorts. SYNT-101 is being developed as a once-daily pill for the treatment of obesity. SYNT-101 works by transiently blocking nutrient absorption in the pro

Dr Jaime Ponce has officially assumed the presidency of the International Federation for the Surgery and Other Therapies for Obesity (IFSO) during the closing ceremony of the XXIX IFSO World Congress in Toronto. Ponce received the leadership of the Federation from outgoing President, Dr Khaled Gawdat of Egypt, whom he recognised for his dedicated service and important contributions to IFSO and the global obesity-care community. "It is a tremendous honour to serve as President

A new Scientific Statement released by the Endocrine Society highlights the benefits of obesity treatment beyond weight loss, including improvements in overall health and reducing the risk of conditions such as heart disease, sleep apnoea and liver disease. Obesity is a complex, chronic disease influenced by biology, genetics, metabolism, the brain, and environmental factors, not simply a matter of willpower. The disease affects over 40% of American adults and costs over $173

Epicyt Pharma has announced positive topline results from its Phase 1/2a first-in-human study of BAFA, a first‑in‑class oral drug candidate combining a bile acid and a short‑chain fatty acid to enhance intestinal calcium uptake, in patients following Roux-en-Y gastric bypass (RYGB) surgery. The study demonstrated a statistically significant reduction in urinary calcium excretion together with improvements in key biomarkers of calcium homeostasis. Based on these encouraging fi

Metabolic and bariatric surgery improves menstrual cycle frequency and symptoms of polycystic ovaries in women living with obesity, according to a study from the University of Surrey. The research team recommends that preconception care and reproductive counselling be made available to women who undergo this weight-loss surgery to help improve their reproductive health. During the study, Surrey researchers investigated the impact of metabolic surgery on the menstrual cycle, h